Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-08-10 Sale | 2021-08-12 4:20 pm | Fulcrum Therapeutics Inc. | FULC | Moxham Christopher Chief Scientific Officer | 51,785 | $17.6 | $911,416 | 176,073 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-08-10 Exercise | 2021-08-12 4:20 pm | N/A 2029-01-21 | Fulcrum Therapeutics Inc. | FULC | Moxham Christopher Chief Scientific Officer | 51,785 | $0 | 176,073 (Direct) | View |
| 2021-08-10 Exercise | 2021-08-12 4:20 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Moxham Christopher Chief Scientific Officer | 51,785 | $7.84 | 176,073 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 4:30 pm | N/A 2031-02-07 | Fulcrum Therapeutics Inc. | FULC | Moxham Christopher Chief Scientific Officer | 100,000 | $0 | 100,000 (Direct) | View |
Ownership | 2021-02-10 4:15 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Moxham Christopher Chief Scientific Officer | 0 | $0 | 186,495 (Direct) | View |